[Selected problems of manufacturing influenza vaccines].
In the study chosen issues of manufacturing influenza vaccines running to increase effectiveness were performed. New concepts into development of process of safety and efficacy influenza vaccines are connected with use a new adjuvants, use of alternative routes of administration of vaccine, new structural virus subunits including DNA, new way of virus culture and use of live, attenuated vaccines.
Augustynowicz
Ewa
E
Zakład Badania Surowic i Szczepionek, Narodowego Instytutu Zdrowia Publicznego- Państwowego Zakładu Higieny w Warszawie. eaugustynowicz@pzh.gov.pl
D003132:Commerce / Q000592:standards*; D004531:Eggs / Q000821:virology*; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000254:growth & development* / Q000276:immunology / Q000502:physiology; D007252:Influenza Vaccines / Q000096:biosynthesis* / Q000276:immunology / Q000592:standards; D007251:Influenza, Human / Q000517:prevention & control; D011044:Poland; D012449:Safety; D014613:Vaccines, Attenuated / Q000096:biosynthesis* / Q000276:immunology; D014776:Virus Cultivation / Q000379:methods; D014779:Virus Replication
D007252:Influenza Vaccines; D014613:Vaccines, Attenuated